April 2025

Highlights from Heart Rhythm 2025: PFA takes center stage | Building an Atrial Fibrillation Center of Excellence | AI & ablation ()
The evolution of AI in cardiology | Champagne may be good for the heart | Bayer's finerenone linked to key benefits ()
PFA tech takes center stage | FDA approves smallest defibrillation lead of its kind | A new risk calculator for surgeons ()
FDA approves leadless CRT device for heart failure | Heart pump accessories recalled | Implantable IVC sensor shows potential ()
Test newsletter 4-28-2025 ()
Heart pump accessories recalled | AI helps terminate AFib | Vendor payments & LAAO volume | Robotic mitral repair & the elderly ()
Week in Review: Patient's family awarded $45M | The CVB 40 Under 40 | Catheters pulled from market | AFib Centers of Excellence ()
Progress for Medtronic & Abbott | Same-day discharge after ablation | Self-expanding TAVR after 5 years | PFA startup's new data ()
Cardiologist compensation takes a hit | Family of heart patient awarded $45M after suing health system | A message to RFK Jr ()
How to build an AFib Center of Excellence | Stroke devices recalled | Cardiologists make history | Body fat & TAVR outcomes ()
FDA chooses not to approve nasal spray for heart rhythm issues | Quality & ACO participation | Progress for Abbott's PFA tech ()
Advanced hypertension tech impresses FDA | SCAI wants better radiation protection | Proactive CAD strategies make an impact ()
Major trends in ACS care | Valve oversizing & PVL | Comparing balloon-expandable TAVR valves | AI tracks long-term heart risks ()
FDA warns that imaging catheters may be unsafe | The power of AI-based plaque evaluations | Patient's family awarded $45M ()
Week in Review: FDA approves leadless CRT device for HF | Cardiologist compensation drops | When SAVR is preferred over TAVR ()
Breaking News: FDA warns that certain coronary imaging catheters are being removed from market ()
FDA clears advanced TAVR pacing technology | The challenges of diagnosing CAD in women | Cardiologist accused of sexual abuse ()
FDA clears 4D visualization platform | Tricuspid valve surgery outcomes | Real-world TAVR data vs. clinical trials ()
FDA approves leadless CRT device, AI imaging software | Drug helps surgeons avoid a 'bloody mess' | IVC implant shows promise ()
FDA clears interventional device | Safety issues leads to recall | TAVR valve used for first time | Shockwave tests new IVL tech ()
When surgery, not TAVR, remains the best choice | Significant policies in interventional cardiology | A key approval for Edwards ()
New drug shows potential to treat AS | CMS approves TTVR coverage | TAVR or TAVI? | Mitral valve repair vs. replacement ()
Cardiologist compensation on the decline | Adding red meat to a Mediterranean diet | How to help older heart failure patients ()
Week in Review: New TAVR valve used for the first time | Medicare coverage for T-TEER | Starfish-shaped heart monitors ()
TAVR for pure aortic regurgitation performs well | New echo contrast agent enters U.S. trials ()
Science should trump politics in healthcare | ACC asks congress fund cardiac arrest law | Evolut low-risk TAVR data at 5-years ()
Key drug trials from ACC.25 | Deaths after TAVR on the rise | FDA clears new device for heart access | Fake doc now in custody ()
Fully retrievable TAVR valve used for very first time | IVL for challenging coronary lesions | A new way to reach AS patients ()
CMS proposes Medicare coverage for T-TEER | Permanent pacemakers after TAVR | Starfish-shaped heart devices use the power of AI ()
Week in Review: Surgical devices recalled | Managing asymptomatic AS | Highlights from ACC.25 | The power of plant-based diets ()
Does ACO participation improve care? | Florida cardiologist arrested | Big IVL news for Boston Scientific | ACC's new president ()
Key takeaways from ACC late-breakers | Pregnancy blood pressure tied to hypertension later | EP advocates get to work ()
New TAVR data on asymptomatic AS & heart failure | Bringing high-quality care to Florida | AHA takes on stroke outcomes ()
March's Top Stories: Transplant ends in tragedy | Device recalls | A new drug for AS | ACS guidelines | Medicare covering TTVR ()
The case against routine interventions for asymptomatic AS | Surgical devices recalled | Key benefits of plant-based diets ()